Back |
home / stock / mdwd / mdwd message board
Subject | By | Source | When |
---|---|---|---|
$MDWD article in Hebrew Goog translated: | midastouch017 | investorshub | 12/29/2022 1:43:17 PM |
https://www.mediwound.com/products/ | midastouch017 | investorshub | 12/24/2022 3:33:27 PM |
MediWound's burn treatment Nexobrid approved in Japan | midastouch017 | investorshub | 12/23/2022 2:08:50 PM |
Oppenheimer Adjusts MediWound Price Target to $63 From | midastouch017 | investorshub | 12/23/2022 1:30:15 PM |
Japan is the first country in the world | midastouch017 | investorshub | 12/23/2022 1:28:38 PM |
Maxim Group Initiates Coverage on MediWound With Buy | midastouch017 | investorshub | 12/23/2022 5:26:15 AM |
MediWound Strengthens European Presence of NexoBrid | midastouch017 | investorshub | 12/20/2022 1:16:38 PM |
MediWound Announces Positive Results in U.S. Phase I/II | midastouch017 | investorshub | 12/19/2022 12:34:30 PM |
MediWound Expands Global Presence as NexoBrid Gains Approval | midastouch017 | investorshub | 12/13/2022 1:21:47 PM |
MediWound Ltd. plans to enact a 1-for-7 reverse | realfast95 | investorshub | 12/05/2022 9:49:27 PM |
MediWound Ltd. ($MDWD) Q3 2022 Earnings Call Transcript | midastouch017 | investorshub | 11/15/2022 5:51:24 PM |
MediWound Reports Third Quarter 2022 Financial Results and | midastouch017 | investorshub | 11/15/2022 12:37:44 PM |
News, Short Squeeze, Breakout and More Instantly...
Funds to be used for clinical development of EscharEx ® to treat diabetic foot ulcers (DFUs) Award advances MediWound’s DFU program and its future revenues four years ahead of original schedule YAVNE, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd....
Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd PR Newswire GOTHENBURG, Sweden , July 15, 2024 /PRNewswire/ -- Mölnlycke Health Care, a world-leading MedTech company specialising i...
YAVNE, Israel, July 15, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the world leader in next-generation enzymatic therapeutics for tissue repair, today announced it has entered into a definitive share purchase agreement with several new and existing investors, including Mölnlycke...